These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12559797)

  • 1. Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts.
    Peters C; Paterson Y
    Vaccine; 2003 Mar; 21(11-12):1187-94. PubMed ID: 12559797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens.
    Friedman RS; Frankel FR; Xu Z; Lieberman J
    J Virol; 2000 Nov; 74(21):9987-93. PubMed ID: 11024127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge.
    Mata M; Yao ZJ; Zubair A; Syres K; Paterson Y
    Vaccine; 2001 Jan; 19(11-12):1435-45. PubMed ID: 11163666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
    Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
    J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.
    Sewell DA; Shahabi V; Gunn GR; Pan ZK; Dominiecki ME; Paterson Y
    Cancer Res; 2004 Dec; 64(24):8821-5. PubMed ID: 15604239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.
    Peters C; Peng X; Douven D; Pan ZK; Paterson Y
    J Immunol; 2003 May; 170(10):5176-87. PubMed ID: 12734365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
    Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
    Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector.
    Frankel FR; Hegde S; Lieberman J; Paterson Y
    J Immunol; 1995 Nov; 155(10):4775-82. PubMed ID: 7594479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens.
    Mata M; Paterson Y
    J Immunol; 1999 Aug; 163(3):1449-56. PubMed ID: 10415046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity in neonatal mice of a hyperattenuated Listeria vaccine directed against human immunodeficiency virus.
    Rayevskaya M; Kushnir N; Frankel FR
    J Virol; 2002 Jan; 76(2):918-22. PubMed ID: 11752181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage.
    Jensen S; Steffensen MA; Jensen BA; Schlüter D; Christensen JP; Thomsen AR
    J Immunol; 2013 Oct; 191(8):4152-64. PubMed ID: 24043891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of two Listeria monocytogenes vaccines targeting human papillomavirus-16 E7 to induce an antitumor response correlates with myeloid dendritic cell function.
    Peng X; Hussain SF; Paterson Y
    J Immunol; 2004 May; 172(10):6030-8. PubMed ID: 15128786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered Listeria monocytogenes as an AIDS vaccine.
    Lieberman J; Frankel FR
    Vaccine; 2002 May; 20(15):2007-10. PubMed ID: 11983264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.
    zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW
    J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring host immune responses to Listeria by manipulation of virulence genes -- the interface between innate and acquired immunity.
    Peters C; Domann E; Darbouche A; Chakraborty T; Mielke ME
    FEMS Immunol Med Microbiol; 2003 Apr; 35(3):243-53. PubMed ID: 12648843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
    Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
    Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication.
    Boyer JD; Robinson TM; Maciag PC; Peng X; Johnson RS; Pavlakis G; Lewis MG; Shen A; Siliciano R; Brown CR; Weiner DB; Paterson Y
    Virology; 2005 Mar; 333(1):88-101. PubMed ID: 15708595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes.
    Rayevskaya MV; Frankel FR
    J Virol; 2001 Mar; 75(6):2786-91. PubMed ID: 11222702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.
    Sewell DA; Douven D; Pan ZK; Rodriguez A; Paterson Y
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):92-7. PubMed ID: 14732776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens.
    Paterson Y; Johnson RS
    Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S119-34. PubMed ID: 15285711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.